Enochian Biosciences Common Stock

Enochian Biosciences (ENOB) currently reports a common stock of $460 as of June 2026. That compares with $18K in the prior-year period — down 97.4% year over year. Use the charts on this page to explore Enochian Biosciences's common stock history and peer comparisons.

Enochian Biosciences's common stock decreased from $18K to $460 — a 97.4% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Enochian Biosciences reported $460 in common stock as of June 2026. That compares with $18K in the prior-year period — down 97.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $460, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Enochian Biosciences, and consider following ENOB for alerts when major investors trade the stock.

Enochian Biosciences is classified in the Healthcare sector. On common stock, it currently shows $460. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ENOB with unrelated industries.